Freitag, 28. Oktober 2016

  • Pressemitteilung BoxID 60245

Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities

(lifePR) (Bad Homburg v.d.H, ) As a further component of the acquisition financing of APP Pharmaceuticals, Inc., US$ 2,400 million Senior Secured Credit Facilities were successfully offered in a first phase of syndication. Thereof, US$ 1,900 million will be used for the purchase price, the refinancing of APP's existing debt, transaction fees and expenses. US$ 500 million will be available for general corporate purposes, including ongoing working capital requirements. The US$ 650 million revolving facilities and the US$ 900 million Term Loan A have a tenor of 5 years, the US$ 850 million Term Loan B of 6 years.

20 of Fresenius' key relationship banks from Europe, North America and Japan, acting as Mandated Lead Arrangers and Joint Lead Arrangers, have provided strong commitments. Therefore, the target amount has been substantially oversubscribed. Following review of customary documentation, the first phase of syndication is expected to close on August 20, 2008. The general syndication to the broad bank market in Europe and the US will be launched in early September.

The total funded debt financing for the APP transaction was already fully underwritten by the three Senior Mandated Lead Arrangers Deutsche Bank (Global Co-ordinator), Credit Suisse and JP Morgan at the time of announcement of the acquisition.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius AG (SE)

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care. In 2007, group sales were approx. € 11.4 billion. On June 30, 2008 the Fresenius Group had 117,453 employees worldwide. For more information visit the Company's website at .

Diese Pressemitteilungen könnten Sie auch interessieren

Life Traded Insurance Portfolio Germany (Life TIP III) – Versicherungsnehmer realisieren hohe Verluste bei dem Fonds Euro TLSI Class Shares

, Finanzen & Versicherungen, HAHN Rechtsanwälte PartG mbB

Es zeichnete sich bereits über die Jahre ab, dass bei der Life Traded Insurance Portfolio Germany (Life TIP III) erhebliche Verluste insbesondere...

7x7finanz mit zwei neuen Beratern in Siegen

, Finanzen & Versicherungen, 7×7 Unternehmensgruppe c/o 7x7sachwerte GmbH & Co. KG

Die 7x7finanz GmbH hat jetzt ihre Niederlassung in Siegen um zwei weitere Mitarbeiter verstärkt. Seit Anfang Oktober unterstützen Jan-Micha Ströhmann...

7x7 stellt nachhaltige Investments vor

, Finanzen & Versicherungen, 7×7 Unternehmensgruppe c/o 7x7sachwerte GmbH & Co. KG

Die Bonner 7x7finanz GmbH präsentiert sich am 12. November 2016 in Freiburg auf der Messe Grünes Geld. Dort können sich interessierte Anleger...